rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John D. Fowler Jr.

Director

Company insider

Files Form 4 as: Director, Emergent BioSolutions; Director, Beverly Enterprises.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
14 Mar 2006
Last trade
30 Apr 2026
Last filed
4 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
EBS Emergent BioSolutionsDirector · Biotechnology · last 30 Apr 20260 buys · 0 sells
Beverly EnterprisesDirector · last 14 Mar 20060 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
30 Apr 2026filed 4 May 2026EBS Emergent BioSolutionsBiotechnologySEC FORM 4 Code A—25,344 at $0.00filing
30 Apr 2026filed 4 May 2026EBS Emergent BioSolutionsoption or derivative · BiotechnologySEC FORM 4 Code A—11,296 at $0.00filing
30 Apr 2026filed 4 May 2026EBS Emergent BioSolutionsoption or derivative · BiotechnologySEC FORM 4 Code A—11,296 at $0.00filing
30 Apr 2026filed 4 May 2026EBS Emergent BioSolutionsBiotechnologySEC FORM 4 Code A—25,344 at $0.00filing
3 Mar 2026filed 5 Mar 2026EBS Emergent BioSolutionsBiotechnologySEC FORM 4 Code A$45K5,006 at $8.99filing
3 Mar 2026filed 5 Mar 2026EBS Emergent BioSolutionsBiotechnologySEC FORM 4 Code A$45K5,006 at $8.99filing
14 Mar 2006filed 16 Mar 2006Beverly Enterprisesoption or derivativeSEC FORM 4 Code D$97K11,000 at $8.86filing
14 Mar 2006filed 16 Mar 2006Beverly Enterprisesoption or derivativeSEC FORM 4 Code D$23K3,667 at $6.18filing
14 Mar 2006filed 16 Mar 2006Beverly Enterprisesoption or derivativeSEC FORM 4 Code D$52K11,000 at $4.69filing
14 Mar 2006filed 16 Mar 2006Beverly Enterprisesoption or derivativeSEC FORM 4 Code D$964K77,093.72 at $12.50filing
14 Mar 2006filed 16 Mar 2006Beverly EnterprisesSEC FORM 4 Code A—77,093.72filing
14 Mar 2006filed 16 Mar 2006Beverly EnterprisesSEC FORM 4 Code D$964K77,093.72 at $12.50filing
14 Mar 2006filed 16 Mar 2006Beverly EnterprisesSEC FORM 4 Code D$63K5,000 at $12.50filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Donald W. DeGolyerDirector · Director at Emergent BioSolutions, filing Form 4 there in the last year
Paul Anthony WilliamsSVP, Products Business · SVP, Products Business at Emergent BioSolutions, filing Form 4 there in the last year
Richard S. LindahlEVP, Chief Financial Officer · EVP, Chief Financial Officer at Emergent BioSolutions, filing Form 4 there in the last year
William HartzelSVP, Bioservices · SVP, Bioservices at Emergent BioSolutions, filing Form 4 there in the last year
Coleen GlessnerEVP, Quality & Ethics, and CPL · EVP, Quality & Ethics, and CPL at Emergent BioSolutions, filing Form 4 there in the last year